Revisor Wealth Management’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$93.1K Hold
18,520
– – 0.02% 356
2026
Q2
$105K Hold
18,520
– – 0.03% 364
2026
Q1
$79.4K Buy
18,520
+5,317
+40% +$29.6K 0.02% 321
2025
Q4
$90.1K Buy
+13,203
New +$81.8K 0.02% 319

Other funds holding NUVB

Revisor Wealth Management's NUVB Position: Q3 2026 in Review

Revisor Wealth Management held its Nuvation Bio (NUVB) position steady in Q3 2026 at 18,520 shares worth $93.1K. The position accounts for 0.02% of the portfolio, ranked #356.

Revisor Wealth Management first reported a position in NUVB in Q4 2025 and has held it in 4 quarters since. The position peaked at $105K in Q2 2026. 256 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Revisor Wealth Management held 18,520 shares of Nuvation Bio worth $93.1K as of Q3 2026.
  • Revisor Wealth Management left its Nuvation Bio share count unchanged in Q3 2026.
  • Nuvation Bio made up 0.02% of Revisor Wealth Management's portfolio in Q3 2026, its #356 holding.
  • Revisor Wealth Management first reported a position in Nuvation Bio in Q4 2025 and has held it in 4 quarters since.
  • Revisor Wealth Management's Nuvation Bio position peaked at $105K in Q2 2026.
  • 256 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Revisor Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.